CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.270

-3.1%

11:38 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edwin S. Fujinaka who wrote (344)	11/20/2000 12:38:55 PM
From: Jim Oravetz	Read Replies (2) of 668

he Roach Motel Cynthia Robbins-Roth, Forbes ASAP, 11.27.00 forbes.com Over the next 12 months, investors should look for products moving forward, new deals involving genomics and stem cells, and product development partners. CEO Platika expects the Curis discovery engine to generate one or two new product candidates each year. He has more than $50 million in cash, which should pay for another 18 months of activity, so financings are likely to be on the menu. Says Platika, "Look for additional M&A deals. This is part of a rollout, to make sure we can crawl before we run." If all goes well, Platika and Ontogeny may have come up with a great way to get out of the "roach motel." snip<> Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next